Overview
The Cancer Center offers a variety of Advanced Cancer Therapies at Cincinnati Children's Hospital Medical Center. We utilize a core group of highly specialized oncologists trained in the field of high risk cancers to treat pediatric patients with high risk solid tumors.
Building on the existing expertise within the Division of Hematology / Oncology and Experimental Hematology, we are developing a foundation of integrated clinical-laboratory research, allowing us to offer patients and their families innovative treatment options.
Our Programs
We also offer second opinions or consultations.
Cancer Center Highlights
- Leadership participation in the National Cancer Institute Phase I Consortium, the NANT (New Approaches to Neuroblastoma Therapy)-Neuroblastoma Consortium and the Children's Oncology Group
- Joint collaboration with the Blood and Marrow Transplantation Program to develop novel therapies (e.g. – therapeutic antibodies, signal transduction inhibitors, and others)
- A new Radiobiologics Therapy Program developing new treatments for high risk neuroblastoma and leukemia / lymphoma
- A new integrated laboratory research core – the Pharmacogenetics / Drug Metabolizing Enzyme Genotyping Program to develop new therapies for high risk malignancies and improve cure rates
